CompaniesGenencine Therapeutics

Genencine Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

3

As Collaborator

0

Total Enrollment

15

By Phase

PHASE1: 3

By Status

UNKNOWN: 3
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
Today
NCT04110964
NCT04133454
NCT04133649
Hover over trial bars to see details

Recent Trials

NCT04133649Lead Sponsor
Evaluation of Safety and Tolerability of Libella Gene Therapy for the Treatment of Aging: AAV- hTERT
PHASE1Unknown
5 participants
Started: Oct 17, 2019 · Completed: Jan 31, 2021
NCT04133454Lead Sponsor
Evaluation of Safety and Tolerability of Libella Gene Therapy for Alzheimer's Disease: AAV- hTERT
PHASE1Unknown
5 participants
Started: Oct 10, 2019 · Completed: Jan 31, 2021
NCT04110964Lead Sponsor
Evaluation of Safety and Tolerability of Libella Gene Therapy for Critical Limb Ischemia: AAV- hTERT
PHASE1Unknown
5 participants
Started: Sep 26, 2019 · Completed: Dec 31, 2020